Senores Pharmaceuticals Limited has announced its Q3FY26 earnings conference call, scheduled to take place on Tuesday, January 20, 2026, at 4:30 PM IST.

The call will be held following the announcement of the company's un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025.

The conference call is being organized by Ambit Capital and will feature key management personnel, including Managing Director Mr. Swapnil Shah, Chairman Mr. Sanjay Majmudar, Chief Financial Officer Mr. Deval Shah, and Chief Operating Officer Mr. Chetan Shah. The call will be moderated by Gaurav Tinani from Institutional Equities, Ambit Capital.

Details for joining the conference call have been provided, including dial-in numbers for India, Singapore, Hong Kong, USA, and the UK. Participants are advised to join a few minutes prior to the scheduled time. The company will subsequently publish the audio recording and transcript of the call on its website.